Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | KRYS | HALO | ||
| Company | Immunitybio Inc | Krystal Biotech Inc | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.34 | 308.00 | 68.03 | ||
| High | 8.53 | 308.99 | 69.32 | ||
| Low | 7.74 | 289.39 | 66.90 | ||
| Latest | 8.00 | 291.75 | 67.44 | ||
| Change | +0.03 | -14.54 | +0.32 | ||
| % Change | +0.38% | -4.75% | +0.48% | ||
| Volume | 13,084,800 | 299,200 | 1,780,900 | ||
| 20-Day Average Volume | 12,081,175 | 322,450 | 1,760,300 | ||
| Previous Close | 7.97 | 306.29 | 67.12 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.77 | 286.62 | 66.25 | ||
| 20-Day Raw Stochastic | 64.80% | 58.92% | 43.96% | ||
| 20-Day Relative Strength | 52.34 | 55.07 | 51.68 | ||
| Weighted Alpha | +35.57 | +122.21 | +16.67 | ||
| Today's Opinion | 96% Buy | 100% Buy | 24% Sell | ||
| Previous Opinion | 96% Buy | 88% Buy | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.36% since 05/11/26 | -6.75% since 05/11/26 | +1.55% since 05/11/26 | ||
| Low | 7.74 on 05/18/26 | 289.39 on 05/18/26 | 66.31 on 05/15/26 | ||
| High | 8.53 on 05/18/26 | 319.48 on 05/14/26 | 73.89 on 05/12/26 | ||
| 1-Month | |||||
| %Chg | +3.90% since 04/17/26 | +6.40% since 04/17/26 | -2.67% since 04/17/26 | ||
| Low | 6.73 on 04/29/26 | 251.97 on 05/04/26 | 62.38 on 05/01/26 | ||
| High | 8.69 on 05/11/26 | 319.48 on 05/14/26 | 73.89 on 05/12/26 | ||
| 3-Month | |||||
| %Chg | -6.32% since 02/18/26 | +2.99% since 02/18/26 | -7.91% since 02/18/26 | ||
| Low | 6.54 on 03/24/26 | 242.00 on 03/31/26 | 61.33 on 03/27/26 | ||
| High | 12.43 on 02/25/26 | 319.48 on 05/14/26 | 73.94 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | +280.95% since 11/18/25 | +42.50% since 11/18/25 | -3.79% since 11/18/25 | ||
| Low | 1.95 on 12/31/25 | 203.17 on 11/20/25 | 61.22 on 12/11/25 | ||
| High | 12.43 on 02/25/26 | 319.48 on 05/14/26 | 82.22 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,378,832 | 8,600,787 | 7,999,261 | ||
| Shares Outstanding, K | 1,047,354 | 29,480 | 118,613 | ||
| Annual Sales | 113,290,000 | 389,130,000 | 1,396,610,000 | ||
| Annual Net Income | -351,400,000 | 204,830,000 | 316,890,000 | ||
| Last Quarter Sales | 44,210,000 | 116,360,000 | 376,710,000 | ||
| Last Quarter Net Income | -632,780,000 | 55,930,000 | 150,050,000 | ||
| 60-Month Beta | 0.02 | 0.50 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 05/07/26 | 1.83 on 05/04/26 | 1.60 on 05/11/26 | ||
| Earnings Date | 08/04/26 | 08/03/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.95 | 15.87 | ||